Related Experiment Videos
Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management
Walid Hassan1, Hani Al-Sergani, Walid Mourad
1Department of Cardiovascular Disease, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia. hassanw@kfshrc.edu.sa
Insights
Cardiovascular amyloidosis involves protein buildup in the heart, often causing heart failure. New imaging reduces the need for biopsies, but patient outlook remains poor, highlighting the need for better treatments.
Area of Science:
- Cardiology
- Pathology
- Medical Research
Background:
- Amyloidosis is characterized by extracellular deposition of fibrillar proteins.
- Cardiovascular amyloidosis presents as primary, systemic, or secondary to chronic diseases.
- Common manifestations include restrictive congestive heart failure and conduction abnormalities.
Purpose of the Study:
- To present new insights and recent advances in cardiovascular amyloidosis.
- To review the current understanding of amyloidosis affecting the heart.
Main Methods:
- Review of recent developments in imaging techniques.
- Evaluation of extracardiac tissue sampling methods.
- Minimizing the need for invasive endomyocardial biopsy.
Main Results:
- Advances in imaging and tissue sampling reduce reliance on endomyocardial biopsy.
- Cardiovascular amyloidosis often presents with a restrictive infiltrative pattern.
- Prognosis remains poor and is dependent on the specific amyloidosis type.
Conclusions:
- Cardiovascular amyloidosis is a serious condition with limited treatment options.
- Improved diagnostic methods are crucial for timely intervention.
- Further research is needed to enhance treatment strategies and patient outcomes.
Abstract:
Amyloidosis comprises a unique group of diseases that share in common the extracellular deposition of insoluble fibrillar proteins in organs and tissues. Cardiovascular amyloidosis can be primary, a part of systemic amyloidosis, or a result of chronic systemic diseases elsewhere in the body. The most common presentations are congestive heart failure-mainly a restrictive infiltrative pattern--and conduction system disturbances. Recent developments in imaging techniques and extracardiac tissue sampling have minimized the need for invasive endomyocardial biopsy for amyloidosis. Despite advances in treatment, the prognosis for patients with amyloidosis is still poor and depends on the underlying disease type. Herein, we present new insights and recent advances in cardiovascular amyloidosis.
Related Concept Videos
Heart Failure II: Pathophysiology
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiomyopathy V: Interprofessional Care
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiomyopathy I: Introduction and Classification